Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Proof-of-Concept Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand

NCT01683396 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT01683396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01683396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Proof-of-Concept Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand
Lead sponsor
XOMA (US) LLC
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2014
Enrollment
87 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis